The present invention relates to the use of a compound with receptor activator of nuclear factor-kB ligand (RANKL) activity for the manufacture of a topical pharmaceutical formulation for the modulation of local or systemic Treg numbers and the treatment or the prevention of skin-associated or systemic diseases.
申请公布号
WO2007128564(A3)
申请公布日期
2008.01.03
申请号
WO2007EP04045
申请日期
2007.05.08
申请人
IMBA-INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH;PENNINGER, JOSEF;LOSER, KARIN;BEISSERT, STEFAN